Vector systems for prenatal gene therapy: Principles of adenovirus design and production

Methods in Molecular Biology

Volumn 891, Issue , 2012, Pages 55-84

  Alba, Raul ^a   Baker, Andrew H ^a   Nicklin, Stuart A ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

293 cells; Adenovirus; Plaque forming unit; Replication deficient; Targeting; Titer; Viral particle

Indexed keywords

ADENOVIRUS VECTOR;

ADENOVIRUS; ARTICLE; EMBRYO; GENE MUTATION; GENE TARGETING; GENETIC ENGINEERING; GENETIC MANIPULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TROPISM; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

EID: 84934439086     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-873-3_4     Document Type: Article

References (40)

1. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW (1997) Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and5 Science 275: 1320-1323
2. Tomko RP, Xu R, Philipson L (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 94:3352-3356
3. Henry LJ, Xia D, Wilke ME, Deisenhofer J, Gerard RD (1994) Characterisation of the knob domain of the adenovirus type 5 fi ber protein expressed in Escherichia coli J Virol 68:5239-5246
4. Nicklin SA, Wu E, Nemerow GR, Baker AH (2005) The in fl uence of adenovirus fi ber structure and function on vector development for gene therapy. Mol Ther 12:384-393
5. Wu E, Fernandez J, Kaye Fleck S, Von Seggern DJ, Huang S, Nemerow GR (2001) A 50-kDa membrane protein mediates sialic acidindependent binding and infection of conjunctival cells by adenovirus type37 Virology 279: 78-89
6. Arnberg N, Kidd AH, Edlund K, Nilsson J, Pring-Akerblom P, Wadell G (2002) Adenovirus type 37 binds to cell surface sialic acid through a charge-dependent interaction. Virology 302:33-43
7. Arnberg N, Edlund K, Kidd AH, Wadell G (2000) Adenovirus type 37 uses sialic acid as a cellular receptor. J Virol 74:42-48
8. Seiradake E, Henaff D, Wodrich H, Billet O, Perreau M, Hippert C, Mennechet F, Schoehn G, Lortat-Jacob H, Dreja H, Ibanes S, Kalatzis V, Wang JP, Finberg RW, Cusack S, Kremer EJ (2009) The cell adhesion molecule "CAR" and sialic acid on human erythrocytes in fl uence adenovirus in vivo biodistribution. PLoS Pathog 5:e1000277
9. Gaggar A, Shayakhmetov DM, Lieber A (2003) CD46 is a cellular receptor for group B adenoviruses. Nat Med 9:1408-1412
10. Tuve S, Wang H, Ware C, Liu Y, Gaggar A, Bernt K, Shayakhmetov D, Li Z, Strauss R, Stone D, Lieber A (2006) A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells. J Virol 80:12109-12120
11. Huard J, Lochmuller H, Acsadi G, Jani A, Massie B, Karpati G (1995) The route of administration is a major determinant of the transduction ef fi ciency of rat tissues by adenoviral recombinants. Gene Ther 2:107-115
12. Sullivan DE, Dash S, Du H, Hiramatsu N, Aydin F, Kolls J, Blanchard J, Baskin G, Gerber MA (1997) Liver-directed gene transfer into non-human primates. Hum Gene Ther 8: 1195-1206
13. Shayakhmetov DM, Gaggar A, Ni S, Li ZY, Lieber A (2005) Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol 79:7478-7491
14. Parker AL, Waddington SN, Nicol CG, Shayakhmetov DM, Buckley SM, Denby L, Kemball-Cook G, Ni S, Lieber A, McVey JH, Nicklin SA, Baker AH (2006) Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108:2554-2561
15. Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, Atoda H, Pink R, Buckley SM, Greig JA, Denby L, Custers J, Morita T, Francischetti IM, Monteiro RQ, Barouch DH, van Rooijen N, Napoli C, Havenga MJ, Nicklin SA, Baker AH (2008) Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132: 397-409
16. Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, Stewart PL, Shayakhmetov DM (2008) Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo Proc Natl Acad Sci U S A 105:5483-5488
17. Graham FL, Smiley J, Russel WC, Nairu R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type5 J Gen Virol 36:59-72
18. Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, Van Ormondt H, Hoeben RC, Van Der Eb AJ (1996) Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 7:215-222
19. Fallaux FJ, Bout A, van der Velde I, van den Wollenberg DJ, Hehir KM, Keegan J, Auger C, Cramer SJ, van Ormondt H, van der Eb AJ, Valerio D, Hoeben RC (1998) New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replicationcompetent adenoviruses. Hum Gene Ther 9: 1909-1917
20. Feuerbach D, Burgert HG (1993) Novel proteins associated with MHC class-1 antigens in cells expressing the adenovirus protein E3/19K. EMBO J 12:3153-3161
21. Yang Y, Ertl HCJ, Wilson JM (1994) MHC class I restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice transfected with E1 deleted recombinant adenoviruses. Immunity 1:433-442
22. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A 91:4407-4411
23. Dedieu JF, Vigne E, Torrent C, Jullien C, Mahfouz I, Caillaud JM, Aubailly N, Orsini C, Guillaume JM, Opolon P, Delaere P, Perricaudet M, Yeh P (1997) Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses. J Virol 71:4626-4637
24. Brough DE, Hsu C, Kulesa VA, Lee GM, Cantolupo LJ, Lizonova A, Kovesdi I (1997) Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression fro adenovirus vectors in vivo J Virol 71:9206-9213
25. Wang Q, Greenburg G, Bunch D, Farson D, Finer MH (1997) Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector. Gene Ther 4:393-400
26. Alba R, Bosch A, Chillon M (2005) Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther 12:S18-S27
27. Segura MM, Alba R, Bosch A, Chillon M (2008) Advances in helper-dependent adenoviral vector research. Curr Gene Ther 8:222-235
28. Muruve DA, Cotter MJ, Zaiss AK, White LR, Liu Q, Chan T, Clark SA, Ross PJ, Meulenbroek RA, Maelandsmo GM, Parks RJ (2004) Helperdependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo. J Virol 78:5966-5972
29. Bett AJ, Prevec L, Graham FL (1993) Packaging capacity and stability of human adenovirus type 5 vectors. J Virol 67:5911-5921
30. Mitani K, Graham FL, Caskey CT, Kochanek S (1995) Rescue, propagation, and partial puri fi cation of a helper virus-dependent adenovirus vector. Proc Natl Acad Sci USA 92: 3854-3858
31. Xia D, Henry LJ, Gerard RD, Deisenhofer J (1994) Crystal structure of the receptor-binding domain of adenovirus type 5 fi ber protein at 1.7 Å resolution. Structure 2:1259-1270
32. Alba R, Bradshaw AC, Parker AL, Bhella D, Waddington SN, Nicklin SA, van Rooijen N, Custers J, Goudsmit J, Barouch DH, McVey JH, Baker AH (2009) Identi fi cation of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 114: 965-971
33. Shayakhmetov DM, Papayannopoulou T, Stamatoyannopoulos G, Lieber A (2000) Ef fi cient gene transfer into human CD34+ cells by a retargeted adenovirus vector. J Virol 74: 2567-2583
34. Denby L, Work LM, Graham D, Hsu C, von Seggern DJ, Nicklin SA, Baker AH (2004) Adenoviral serotype 5 vectors pseudotyped with fi bers from subgroup D show modi fi ed tropism in vitro and in vivo Hum Gene Ther 15:1054-1064
35. Denby L, Work LM, Seggern DJ, Wu E, McVey JH, Nicklin SA, Baker AH (2007) Development of renal-targeted vectors through combined in vivo phage display and capsid engineering of adenoviral fi bers from serotype 19p. Mol Ther 15:1647-1654
36. He T-C, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B (1998) A simpli fi ed system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95:2509-2514
37. Lowenstein PR, Shering IAF, Bain D, Castro MG, Wilkinson GWG (1996) How to examine the interactions between adenoviral mediated gene transfer and different indenti fi ed target brain cell types in vitro In: Lowenstein PR, Enquist LW (eds) Towards gene therapy for neurological disorders. Wiley, Chichester, UK, pp 93-114
38. Von Seggern DJ, Kehler J, Endo RL, Nemerow GR (1998) Complementation of a fi bre mutant adenovirus by packaging cell lines expressing the adenovirus type 5 fi bre protein. J Gen Virol 79:1461-1468
39. Kirby I, Davidson E, Beavil AJ, Soh CPC, Wickham TJ, Roelvink PW, Kovesdi I, Sutton BJ, Santis G (2000) Identi fi cation of contact residues and de fi nition of the CAR-binding site of adenovirus type 5 binding protein. J Virol 74:2804-2813
40. Roberts DM, Nanda A, Havenga MJ, Abbink P, Lynch DM, Ewald BA, Liu J, Thorner AR, Swanson PE, Gorgone DA, Lifton MA, Lemckert AA, Holterman L, Chen B, Dilraj A, Carville A, Mans fi eld KG, Goudsmit J, Barouch DH (2006) Hexon-chimaeric adenovirus serotype 5 vectors circumvent preexisting anti-vector immunity. Nature 441: 239-243